We are excited to announce that HistologiX will be attending the upcoming conference on Applications of in situ hybridisation and spatial profiling methods in research and disease. This event will take place on May 16-17, 2023, at the Cancer Research UK (CRUK) Cambridge Institute.
Find out more
To mark British Science Week and Women’s History Month we spoke to Rebecca Hanwell about her experiences studying science. Q: Can you tell us about your research progress since completing your MPhil research project at HistologiX? A: Since completion of the MPhil, I have tested Human papillomavirus (HPV) antibodies using immunohistochemical methods on tissue. My…
Find out more
We’re thrilled to announce that HistologiX will be attending the upcoming Scottish Life Sciences Awards, alongside our sister company from the Niche CRO Group, Intelligent Clinical. The Scottish Life Sciences Awards is a prestigious event that recognises the achievements and contributions of companies and individuals in the life sciences sector. It’s an honour to be…
Find out more
HistologiX is proud to announce that we will be attending the Medilink Midlands Business Awards 2023, where we have been nominated for the Partnership between Academia and Business award. The Medilink Midlands Business Awards recognises and celebrates the achievements of businesses and individuals in the healthcare and life sciences sector. The Partnership between Academia and…
Find out more
If you’ve conducted a Tissue Cross-Reactivity (TCR) study and are planning to bring a biologic to market, chances are you’ll need approval from a regulatory body. In the United States that regulatory body is the Food and Drug Administration (FDA) and the FDA has been regulating TCR studies since 1983. History of the FDA Tissue…
Find out more
As experts in cellular and digital pathology, we often get asked about the importance of Tissue cross-reactivity (TCR) studies especially by people new to the drug development process. These studies are an essential tool for evaluating the binding properties of biologics, in different human and non-human tissues. They form a crucial part of the regulatory…
Find out more
HistologiX is proud to not only attend, but also sponsor the Biomarkers Series UK conference hosted by Oxford Global. As a sponsor, we are committed to supporting the advancement of biomarker research and promoting collaboration between industry leaders and experts in the field.
Find out more
The use of tissue cross-reactivity (TCR) assays is the most common method for checking for cross-reaction in monoclonal antibodies. These assays are designed to use the lock and key concept of antibody-antigen binding to test for off-target and on-target binding sites. It is important to use high-quality tissue samples and to interpret the results accurately with the help of experienced professionals to avoid potential pitfalls in the drug development process.
Find out more
We are thrilled to be working with Antibody Analytics to expand our offering and provide our customers with even more advanced solutions. This strategic partnership is an exciting opportunity for both companies and allows us to provide support from early discovery to clinical testing for targeted biologics.
Find out more
The Scotsman's Life Sciences Conference is the annual meeting for the growing life science sector. Joining leaders from industry, government, the NHS and academia to hear where effort will be concentrated in order to grow the industry and see how like-minded business leaders are realising global ambitions for their company. Our Managing Director Barbara McManus will be attending.
Find out more